Form 4 for CVS CVS Health
Accepted 2025-04-03 00:00:00 ET · period of report 2025-04-01 · accession 0001127602-25-011416 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-03 | 2025-04-01 | CVS | Nelson Steven H | EVP, Pres, Aetna | A - Grant | $67.98 | +21.3K | 21.3K | New | +$1.45M |
| D | 2025-04-03 | 2025-04-01 | CVS | Nelson Steven H | EVP, Pres, Aetna | A - Grant | $67.98 | +90.5K | 90.5K | New | +$6.15M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock (Restricted) | 2025-04-01 | A | A | 21,329 | $67.98 | 21,329 | D | — | — | |
| 2 | Derivative | Stock Option | 2025-04-01 | A | A | 90,455 | $67.98 | 90,455 | D | $67.98 · 2026-04-01 to 2035-04-01 | 90,455 Common Stock | (F2) Option becomes exercisable in four equal annual installments, commencing on 4/1/2026. |